445 related articles for article (PubMed ID: 27155851)
1. Mechanisms of tumor cell resistance to the current targeted-therapy agents.
Khamisipour G; Jadidi-Niaragh F; Jahromi AS; Zandi K; Hojjat-Farsangi M
Tumour Biol; 2016 Aug; 37(8):10021-39. PubMed ID: 27155851
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
3. [Cellular and molecular mechanisms of carcinogenic side effects and resistance to BRAF inhibitors in metastatic melanoma with BRAFV600 mutation: state of the knowledge].
Capovilla M
Ann Pathol; 2013 Dec; 33(6):375-85. PubMed ID: 24331719
[TBL] [Abstract][Full Text] [Related]
4. Cancer drug resistance: an evolving paradigm.
Holohan C; Van Schaeybroeck S; Longley DB; Johnston PG
Nat Rev Cancer; 2013 Oct; 13(10):714-26. PubMed ID: 24060863
[TBL] [Abstract][Full Text] [Related]
5. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
6. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of multidrug resistance in cancer.
Gillet JP; Gottesman MM
Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
[TBL] [Abstract][Full Text] [Related]
8. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
Zhang K; Yuan Q
J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
Hua H; Kong Q; Yin J; Zhang J; Jiang Y
J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
[TBL] [Abstract][Full Text] [Related]
11. Novel and emerging targeted-based cancer therapy agents and methods.
Hojjat-Farsangi M
Tumour Biol; 2015 Feb; 36(2):543-56. PubMed ID: 25663495
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of resistance of cancer stem cells to chemotherapy].
Pascussi JM
Bull Cancer; 2017 Dec; 104(12):1080-1084. PubMed ID: 29173972
[No Abstract] [Full Text] [Related]
13. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
14. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
15. Receptor Tyrosine Kinase-Targeted Cancer Therapy.
Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
Zhang D; Fan D
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
18. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells and chemosensitivity.
Maugeri-Saccà M; Vigneri P; De Maria R
Clin Cancer Res; 2011 Aug; 17(15):4942-7. PubMed ID: 21622723
[TBL] [Abstract][Full Text] [Related]
20. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
